Who owns K-V Pharmaceutical Company?
Key information on K-V Pharmaceutical Company (Ticker: KV.B)
- CUSIP: 482740107
Who owns K-V Pharmaceutical Company?
Is KV.B a good stock to own? Find out who bought K-V Pharmaceutical Company, who sold K-V Pharmaceutical Company (KV.B) stock, and who holds a large position in K-V Pharmaceutical Company.
- GOLDMAN SACHS owns 85790 shares worth $72063
- Oppenheimer & Co owns 78312 shares worth $65782
- TSP Capital Management owns 56928 shares worth $47819
- Nomura Holdings owns 770 shares worth $0
- UBS AG owns 363 shares worth $500
- Wells Fargo & Company owns 337 shares worth $0
Who sold K-V Pharmaceutical Company?
- Renaissance Technologies sold on March 31, 2011
- Barclays sold on March 31, 2011
Funds that own KV.B also own:
- Comcast Corporation (CMCSA)
- Vale (VALE)
- iShares FTSE/Xinhua China 25 Index (FXI)
- iShares MSCI Emerging Markets Indx (EEM)
- Berkshire Hathaway (BRK.B)
- Health Care SPDR (XLV)
- iShares Russell 1000 Value Index (IWD)
- iShares MSCI EAFE Index Fund (EFA)
- Discovery Communications (DISCA)
- Energy Select Sector SPDR (XLE)
- iShares Russell 2000 Index (IWM)
- iShares MSCI Japan Index (EWJ)
- iShares Russell 1000 Growth Index (IWF)
- iShares MSCI Brazil Index (EWZ)
- Consumer Staples Select Sect. SPDR (XLP)
- Financial Select Sector SPDR (XLF)
- SPDR KBW Bank (KBE)
- iShares Dow Jones US Real Estate (IYR)
- iShares iBoxx $ High Yid Corp Bond (HYG)
- Consumer Discretionary SPDR (XLY)
- iShares MSCI South Korea Index Fund (EWY)